From Clinical Microbiology to Infection Pathogenesis: How Daring To Be Different Works forStaphylococcus lugdunensis
Top Cited Papers
- 1 January 2008
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 21 (1) , 111-133
- https://doi.org/10.1128/cmr.00036-07
Abstract
Staphylococcus lugdunensis has gained recognition as an atypically virulent pathogen with a unique microbiological and clinical profile. S. lugdunensis is coagulase negative due to the lack of production of secreted coagulase, but a membrane-bound form of the enzyme present in some isolates can result in misidentification of the organism as Staphylococcus aureus in the clinical microbiology laboratory. S. lugdunensis is a skin commensal and an infrequent pathogen compared to S. aureus and S. epidermidis, but clinically, infections caused by this organism resemble those caused by S. aureus rather than those caused by other coagulase-negative staphylococci. S. lugdunensis can cause acute and highly destructive cases of native valve endocarditis that often require surgical treatment in addition to antimicrobial therapy. Other types of S. lugdunensis infections include abscess and wound infection, urinary tract infection, and infection of intravascular catheters and other implanted medical devices. S. lugdunensis is generally susceptible to antimicrobial agents and shares CLSI antimicrobial susceptibility breakpoints with S. aureus. Virulence factors contributing to this organism's heightened pathogenicity remain largely unknown. Those characterized to date suggest that the organism has the ability to bind to and interact with host cells and to form biofilms on host tissues or prosthetic surfaces.Keywords
This publication has 229 references indexed in Scilit:
- Poly- N -Acetylglucosamine Is Not a Major Component of the Extracellular Matrix in Biofilms Formed by icaADBC -Positive Staphylococcus lugdunensis IsolatesInfection and Immunity, 2007
- Acute Postoperative Endophthalmitis Caused by Staphylococcus lugdunensisJournal of Clinical Microbiology, 2007
- Genetic Basis of Resistance to Fusidic Acid in StaphylococciAntimicrobial Agents and Chemotherapy, 2007
- In Vitro Effects of Antimicrobial Agents on Planktonic and Biofilm Forms of Staphylococcus lugdunensis Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2007
- Tolerance to the Glycopeptides Vancomycin and Teicoplanin in Coagulase-Negative StaphylococciAntimicrobial Agents and Chemotherapy, 2007
- In Vitro Activity of Ceftobiprole against Aerobic and Anaerobic Strains Isolated from Diabetic Foot InfectionsAntimicrobial Agents and Chemotherapy, 2006
- Clinical Significance of Coagulase-Negative Staphylococci Recovered from Nonsterile SitesJournal of Clinical Microbiology, 2006
- The Presence of Peptidoglycan O -Acetyltransferase in Various Staphylococcal Species Correlates with Lysozyme Resistance and PathogenicityInfection and Immunity, 2006
- Accessory Gene Regulator Locus of Staphylococcus intermediusInfection and Immunity, 2006
- Whole-Genome Sequencing of Staphylococcus haemolyticus Uncovers the Extreme Plasticity of Its Genome and the Evolution of Human-Colonizing Staphylococcal SpeciesJournal of Bacteriology, 2005